Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity
Science Advances · 03.04.2026 · 12 (14)
DOI: 10.1126/sciadv.aea9268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 03.04.2026. Verfasst von Xinyu Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated H…. Hauptthemen laut MEDLINE: Cryoelectron Microscopy, Receptors, Purinergic P2X3, Receptors, Purinergic P2X2, Protein Multimerization. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, CAS “Light of West China” Program, Jiangxi Province Natural Science Foundation.
Abstract (Originalsprache)
P2X3 receptors are key mediators of adenosine 5′-triphosphate (ATP)–evoked cough reflexes and validated drug targets, but first-generation antagonists such as gefapixant are limited by off-target inhibition of P2X2/3 heteromers in taste pathways. Here, we report the first cryo–electron microscopy (cryo-EM) structures of the human P2X2/3 heteromer in multiple ligand-bound states. The structures resolve its debated stoichiometries (1:2 and 2:1), reveal asymmetric pore organization, and identify heteromer-specific rearrangements that modulate ATP binding and gating. Structural and functional analyses show that gefapixant binds a conserved interfacial allosteric pocket, explaining its poor selectivity and taste-related side effects, whereas the next-generation antagonist camlipixant exploits a divergent vestibular site unique to P2X3, conferring >10,000-fold selectivity and improved tolerability. These findings establish a structural framework for P2X2/3 assembly and drug recognition and provide a roadmap for rational design of selective P2X modulators with enhanced safety and efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiang…
- Jiangxi Provincial Key Laboratory of Tumor Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
- School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Shenzhen Crystalo Biopharmaceutical Co., Ltd., Shenzhen, Guangdong 518118, China.
ORCID-Profile: Xinyu Cheng, Tong Che, Hongmin Guo, Ying Fu, Jin Zhang
Förderung
- National Natural Science Foundation of China
- CAS “Light of West China” Program
- Jiangxi Province Natural Science Foundation
Zitieren
APA
Cheng, X., Zhang, W., Che, T., Guo, H., Nan, W., Zhang, Y., Fu, Y., Wan, S., & Zhang, J. (2026). Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity. Science Advances, 12(14). https://doi.org/10.1126/sciadv.aea9268
Vancouver
Cheng X, Zhang W, Che T, Guo H, Nan W, Zhang Y, et al. Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity. Science Advances. 2026;12(14). doi:10.1126/sciadv.aea9268
BibTeX
@article{Cheng2026,
author = {Cheng, Xinyu and Zhang, Wei and Che, Tong and Guo, Hongmin and Nan, Weiwei and Zhang, Yuting and Fu, Ying and Wan, Shuangyan and Zhang, Jin},
title = {Cryo-EM structures of human P2X2/3 heteromer channel reveal the structural basis of ligand selectivity},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {14},
doi = {10.1126/sciadv.aea9268}
}
EUVIMED